 |
two identical 11-mer oligodeoxynucleotide phosphorothioate sequences linked together at their 3′-ends by glycerol-1,3-diphosphorothioate linkages |
|---|---|
| Trade Name | |
| Orphan Indication | Melanoma stages IIb-IV |
| USA Market Approval | USA |
| USA Designation Date | 2017-06-21 00:00:00 |
| Sponsor | Idera Pharmaceuticals, Inc.;167 Sidney Street;Cambridge, Massachusetts, 02139 |
